Jonathan I. Epstein

Active 1984–2025

Also published as
Jonathan I Epstein
446
Papers
84,711
Citations
155
h-index
436
i10-index

Citations

Citations per year for Jonathan I. Epstein1952: 2 citations1956: 2 citations1971: 1 citations1978: 3 citations1986: 1 citations1987: 10 citations1988: 11 citations1989: 15 citations1990: 23 citations1991: 56 citations1992: 63 citations1993: 139 citations1994: 207 citations1995: 248 citations1996: 274 citations1997: 388 citations1998: 384 citations1999: 374 citations2000: 398 citations2001: 557 citations2002: 427 citations2003: 534 citations2004: 587 citations2005: 544 citations2006: 528 citations2007: 552 citations2008: 535 citations2009: 453 citations2010: 528 citations2011: 512 citations2012: 502 citations2013: 523 citations2014: 558 citations2015: 462 citations2016: 645 citations2017: 459 citations2018: 558 citations2019: 1,579 citations2020: 1,596 citations2021: 1,360 citations2022: 1,026 citations2023: 638 citations2024: 1,088 citations2025: 455 citations2026: 18 citations1953–1955: no citations, so these years are not shown1957–1970: no citations, so these years are not shown1972–1977: no citations, so these years are not shown1979–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,286 citing papers, 34.3% of this breakdownItaly: 1,059 citing papers, 5.8% of this breakdownCanada: 1,024 citing papers, 5.6% of this breakdownUnited Kingdom: 1,012 citing papers, 5.5% of this breakdownGermany: 1,004 citing papers, 5.5% of this breakdownChina: 984 citing papers, 5.4% of this breakdownNetherlands: 707 citing papers, 3.9% of this breakdownFrance: 614 citing papers, 3.3% of this breakdownJapan: 490 citing papers, 2.7% of this breakdownAustralia: 470 citing papers, 2.6% of this breakdownSpain: 410 citing papers, 2.2% of this breakdownSweden: 391 citing papers, 2.1% of this breakdown
0%34.3%Other 21.1%

Fields

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Computer Science4.7%
  • Immunology and Microbiology1%
  • Engineering0.7%
  • Neuroscience0.4%
  • Other2.1%

Topics

  • Prostate Cancer Diagnosis and Treatment14.7%
  • Prostate Cancer Treatment and Research14.7%
  • AI in cancer detection2.8%
  • Urologic and reproductive health conditions2.8%
  • Bladder and Urothelial Cancer Treatments2.6%
  • Renal cell carcinoma treatment2.3%
  • Other60.1%

Coauthors

All papers

Open in search
  1. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

    Authors: , , , , , - The American Journal of Surgical Pathology 2015 cited by 3,188

  2. Genomic and phenotypic heterogeneity in prostate cancer

    Authors: , , , , , , , , - Nature Reviews Urology 2020 cited by 511

  3. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

    Authors: , , , - The American Journal of Surgical Pathology 2005 cited by 2,768

  4. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

    Authors: , , , , , , , , , , , , , , , , - European Urology 2015 cited by 1,368

  5. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Wake, Samuel L. Washington, Alice Yu, Bertram Yuh, Ryan A. Berardi, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2023 cited by 152

  6. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Magi‐Galluzzi, Rohit Mehra, Santosh Menon, Hiroshi Miyamoto, Rodolfo Montironi, George J. Netto, Jane Nguyen, Adeboye O. Osunkoya, Anil V. Parwani, Brian D. Robinson, Mark A. Rubin, Rajal B. Shah, Jeffrey So, Hiroyuki Takahashi, Fabio Tavora, Maria Tretiakova, Lawrence D. True, Sara E. Wobker, Ximing J. Yang, Ming Zhou, Debra L. Zynger, Kiril Trpkov - Archives of Pathology & Laboratory Medicine 2020 cited by 276

  7. Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

    Authors: , , , , , , , , - The American Journal of Surgical Pathology 2014 cited by 576

  8. Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2011 cited by 520

  9. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

    Authors: , , , , , , , - European Urology 2020 cited by 253

  10. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiu Rao, Victor E. Reuter, Rola Saleeb, Rajal B. Shah, Steven C. Smith, Satish K. Tickoo, Maria Tretiakova, Lawrence D. True, Virginie Verkarre, Sara E. Wobker, Ming Zhou, Ondřej Hes - Modern Pathology 2021 cited by 220

  11. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan I. Epstein, Daniel D. Evans, Paul Fulford, Wolfgang B. Gaertner, Jean‐Pierre Gérard, Simon Gollins, Ryan A. Harris, Ewen M. Harrison, J. Heat, Jordan Hill, J Hobbiss, Eduardo Huertas, Zahirul Huq, Soledad Iseas, Anders Jakobsen, Derek A. Jones, Leslie S. Jones, Uzair Ali Khan, RS Kushwaha, Nicholas P. Lees, TY Linn, S Loganathan, Fernando López‐Campos, Robert D. Madoff, З. З. Мамедли, Anna Martling, Klaus E. Matzel, Jarno Melenhorst, Philip B. Mitchell, Sthela M. Murad‐Regadas, Sarah O’Dwyer, Alejandro Pairola, Marius Paraoan, Oriol Parés, Koen Peeters, S H Pettit, N Pranesh, R Rajaganeshan, Srinivasan Ravi, Shyamji Rawat, David M. Richards, K Riyad, Gustavo Rossi, H.J.T. Rutten, M. Saeed, J.R. Salaman, Fernando Sánchez Loria, Marit E. van der Sande, Inês Santiago, Chelliah Selvasekar, K.H. Siddiqui, Christopher J. Smart, Mamoon Solkar, Arthur Sun Myint, Bruce Taylor, Karen Telford, Nigel Scott, Carlos Vaccaro, Bruna Borba Vailati, C Verberne, Pedro Vieira, Dale Vimalchandran, Sarah V. Ward, Malcolm Wilson, D. C. Winter, Carlijn Witjes, Albert Wolthuis, Jing Zhang, Zhen Zhang - The Lancet Oncology 2020 cited by 210

  12. Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

    Authors: , , , , , , , , , , , , , - Clinical Cancer Research 2013 cited by 356

  13. Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update

    Authors: , , , , , , - European Urology 2013 cited by 417

  14. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiu Rao, Victor E. Reuter, Rola Saleeb, Rajal B. Shah, Steven C. Smith, Satish K. Tickoo, Maria Tretiakova, Lawrence D. True, Virginie Verkarre, Sara E. Wobker, Ming Zhou, Anthony J. Gill - Modern Pathology 2021 cited by 250

  15. Defining clinically significant prostate cancer on the basis of pathological findings

    Authors: , - Histopathology 2018 cited by 192

  16. Prognostic G leason grade grouping: data based on the modified G leason scoring system

    Authors: , , , - British Journal of Urology 2013 cited by 629

  17. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers

    Authors: , , , , , , - The American Journal of Surgical Pathology 2016 cited by 250

  18. Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?

    Authors: , , , , , - The American Journal of Surgical Pathology 2012 cited by 356

  19. TFEB-amplified Renal Cell Carcinomas

    Authors: , , , , , , , - The American Journal of Surgical Pathology 2016 cited by 154

  20. Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologist

    Authors: , , , , , - Human Pathology 2001 cited by 390

  21. Contemporary Gleason Grading of Prostatic Carcinoma

    Authors: , , , - The American Journal of Surgical Pathology 2017 cited by 292

  22. Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists

    Authors: , , , , , , , , , , , , , , - Human Pathology 2001 cited by 336

  23. Grading of prostatic adenocarcinoma: current state and prognostic implications

    Authors: , - Diagnostic Pathology 2016 cited by 270

  24. Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades

    Authors: , , , - European Urology 2012 cited by 666